Movement Disorders Hospital - Kliniken Beelitz
Welcome,         Profile    Billing    Logout  
 0 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ebersbach, Georg
EMST-PS, NCT05139342: Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients

Recruiting
N/A
75
Europe
expiratory muscle strentgh training (EMST)
Kliniken Beelitz GmbH
Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear Palsy
08/23
12/23
FEEMSA, NCT04706234: Systematic Assessment of Laryngopharyngeal Function in Patients With MSA, PD, and 4repeat Tauopathies

Recruiting
N/A
200
Europe, Japan, RoW
Kliniken Beelitz GmbH, University Hospital Muenster, Medical University of Warsaw, University Hospital Carl Gustav Carus, University of Ulm, Medical University Innsbruck, Hannover Medical School, University of Barcelona
Multiple System Atrophy, Parkinson Disease, Progressive Supranuclear Palsy
12/23
07/24
Gandor, Florin
NCT05357989: A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Completed
3
523
Europe, US
buntanetap/posiphen, Posiphen Tartrate, ANVS401, Placebo
Annovis Bio Inc., TFS Trial Form Support
Parkinson's Disease, Idiopathic
12/23
12/23
TEMPO-3, NCT04542499 / 2019-002951-40: Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations

Completed
3
507
Europe, US, RoW
Tavapadon, PF-06649751, CVL-751, Placebo
Cerevel Therapeutics, LLC
Parkinson Disease
01/24
02/24
TEMPO-2, NCT04223193 / 2019-002950-22: Flexible-Dose Trial in Early Parkinson's Disease (PD)

Active, not recruiting
3
296
Europe, US, RoW
Tavapadon, PF-06649751, CVL-751, Placebo
Cerevel Therapeutics, LLC
Parkinson Disease
10/24
11/24
ACTIVATE, NCT05819359: Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

Recruiting
2
237
Europe, Canada, US
BIA 28-6156 10 mg, BIA 28-6156 60 mg, Placebo
Bial R&D Investments, S.A.
Parkinson's Disease
03/26
07/26
EMST-PS, NCT05139342: Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients

Recruiting
N/A
75
Europe
expiratory muscle strentgh training (EMST)
Kliniken Beelitz GmbH
Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear Palsy
08/23
12/23
FEEMSA, NCT04706234: Systematic Assessment of Laryngopharyngeal Function in Patients With MSA, PD, and 4repeat Tauopathies

Recruiting
N/A
200
Europe, Japan, RoW
Kliniken Beelitz GmbH, University Hospital Muenster, Medical University of Warsaw, University Hospital Carl Gustav Carus, University of Ulm, Medical University Innsbruck, Hannover Medical School, University of Barcelona
Multiple System Atrophy, Parkinson Disease, Progressive Supranuclear Palsy
12/23
07/24
Vogel, Annemarie
EMST-PS, NCT05139342: Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients

Recruiting
N/A
75
Europe
expiratory muscle strentgh training (EMST)
Kliniken Beelitz GmbH
Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear Palsy
08/23
12/23
FEEMSA, NCT04706234: Systematic Assessment of Laryngopharyngeal Function in Patients With MSA, PD, and 4repeat Tauopathies

Recruiting
N/A
200
Europe, Japan, RoW
Kliniken Beelitz GmbH, University Hospital Muenster, Medical University of Warsaw, University Hospital Carl Gustav Carus, University of Ulm, Medical University Innsbruck, Hannover Medical School, University of Barcelona
Multiple System Atrophy, Parkinson Disease, Progressive Supranuclear Palsy
12/23
07/24
Desiree, Sykora
EMST-PS, NCT05139342: Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients

Recruiting
N/A
75
Europe
expiratory muscle strentgh training (EMST)
Kliniken Beelitz GmbH
Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear Palsy
08/23
12/23

Download Options